DATATRAK at Key Global Events in March

CLEVELAND, March 5, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that members of its team will attend and exhibit at industry events in March.

The events include:

21st Anniversary Partnerships in Clinical Trials
March 5-7, 2012
Orlando, Florida

The 21st Anniversary Partnerships in Clinical Trials opens its event with six diverse multi-speaker summits. Partnerships 2012 offers more quality content than any other event of its kind. For more information: www.iirusa.com

BIO-Europe 2012
March 19-21, 2012
Amsterdam, The Netherlands

BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. For more information: www.ebdgroup.com

CBI's 5th Annual Forum on Clinical Trial Management       
March 21-23, 2012
Philadelphia, Pennsylvania

DATATRAK will be demonstrating its NEW uCTMS product, which offers visibility and control of your pipeline. The forum is the industry's only opportunity for in-depth discussion regarding CTMS systems. CBI's 5th Clinical Trial Management Systems is the must-attend event for clinical business and IT professionals to come together to learn from the challenges and successes of their industry counterparts. For more information: www.cbireg.com

24th Annual DIA EuroMeeting
March 26-28, 2012
Copenhagen, Denmark
Booth #235

The EuroMeeting attracts more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organisations, clinical research, regulatory agencies, health ministries, patients' organisations and universities. For more information: www.diahome.org

About DATATRAK

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market announcing its results for the three-month period ending September 30, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.